2 results
Approved WMOCompleted
To compare a new endoscopic brush device with conventional brush cytology and compare the amount of cells obtained by the two different brushes
Approved WMORecruiting
Primary ObjectiveTo assess the effect of ALX148 plus pembrolizumab on 12-month overall survival (OS) rate and objective response rate (ORR) in patients withmetastatic or with unresectable, recurrent HNSCC that is PD-L1 positive (CPS >=1) and…